Although the result of low dose computed tomography (LDCT) screening for high risk smoker for lung cancer (National Lung Screening Trial, NLST) showed 20% of lower lung cancer death compare to chest X-ray screening, which published in 2011, after more than 8 years passed, no European or Asian country has implemented organized lung cancer screening with LDCT, and there are no National Lung Cancer Screening Program globally. In United States, where LDCT lung screening has become standard procedure, the screening rate is extremely low, less than 5%. That is because in spite of the considerable the benefit of the screening, the harms of screening; specifically, most notably due to the high level of false positives, and physical, psychological, and economical burdens. Recently the controversies regarding the harms of LDCT lung screening has been increasingly debated. Also, the novel strategies, such as artificial intelligence and volumetric measurement of suspicious nodules has been adopted for recently launched lung cancer screening clinical trials. However, amid of skeptical opinions increasing globally, Korean Government recently decided to include LDCT lung cancer screening as national cancer screening program, becoming Korea as the first and the only national lung cancer screening program worldwide. Without randomized trial proven to be effective for Korea population, hurried implementation of national lung cancer screening program could have more harmful effect than benefit in terms of public health perspectives.
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Domain and definition Can occur
Physical harms Physical problems, including discomfort, perceived by the patient or significant others. When something is done to a patient, such as a screening test, workup procedures, or treatment.
Psychological harms Psychological problems, including anxiety, depression, or condition-specific distress, perceived by the patient or significant others. At any step of the screening cascade. Includes effects of anticipation of discomfort from a procedure or from effects of a positive screening test or "labeling" from receiving a diagnosis; and psychological effects of ineffective or unnecessary treatment due to screening.
Financial strain Can result from anticipated or real costs due to the cascade, plus the financial consequences of missing work or other expenses related to screening. Includes disruption of previous financial plans.
Opportunity cost
Includes distraction from other health-related activities or self-care, such as exercise or seeking care for other health problems, as well as reduced time or energy for other important or meaningful activities. Not the same as cost of medical care or cost-effectiveness. 
